<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Myometrial Pathology Cheat Sheet</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 20px;
            font-size: 9pt;
        }
        
        h1 {
            color: #7c2d12;
            font-size: 20pt;
            margin-bottom: 5px;
            text-align: center;
        }
        
        .subtitle {
            text-align: center;
            color: #64748b;
            font-size: 10pt;
            margin-bottom: 20px;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 20px;
            font-size: 8pt;
        }
        
        th {
            background-color: #7c2d12;
            color: white;
            padding: 8px;
            text-align: left;
            font-weight: bold;
            border: 1px solid #4a1508;
        }
        
        td {
            border: 1px solid #cbd5e1;
            padding: 6px;
            vertical-align: top;
        }
        
        .entity-col {
            background-color: #fed7aa;
            font-weight: bold;
            width: 12%;
        }
        
        .clinical-col { width: 13%; }
        .gross-col { width: 13%; }
        .histo-col { width: 18%; }
        .ihc-col { width: 12%; }
        .ddx-col { width: 15%; }
        .pearls-col { width: 17%; }
        
        .key-concepts {
            background-color: #fef3c7;
            border: 2px solid #ca8a04;
            padding: 15px;
            margin-bottom: 20px;
            page-break-inside: avoid;
        }
        
        .key-concepts h2 {
            color: #854d0e;
            font-size: 13pt;
            margin-top: 0;
            margin-bottom: 10px;
        }
        
        .key-concepts h3 {
            color: #a16207;
            font-size: 10pt;
            margin-top: 10px;
            margin-bottom: 5px;
        }
        
        .key-concepts ul {
            margin: 5px 0;
            padding-left: 20px;
        }
        
        .key-concepts li {
            margin-bottom: 3px;
            font-size: 9pt;
        }
        
        .footer {
            text-align: center;
            color: #64748b;
            font-size: 8pt;
            margin-top: 20px;
        }
        
        .abbreviations {
            background-color: #dbeafe;
            border: 2px solid #1e40af;
            padding: 10px;
            margin-bottom: 20px;
            font-size: 9pt;
        }
        
        .abbreviations h3 {
            color: #1e40af;
            font-size: 11pt;
            margin-top: 0;
            margin-bottom: 8px;
        }
        
        .abbr-item {
            margin-bottom: 3px;
        }
        
        .high-yield {
            color: #dc2626;
            font-weight: bold;
        }
        
        @media print {
            body {
                margin: 0;
            }
            .no-print {
                display: none;
            }
        }
    </style>
</head>
<body>
    <h1>MYOMETRIAL PATHOLOGY CHEAT SHEET</h1>
    <div class="subtitle">ABP Gynecologic & Placenta Section: 8% Written, 7% Virtual Microscopy</div>
    
    <button class="no-print" onclick="window.print()" style="position: fixed; top: 10px; right: 10px; padding: 10px 20px; background-color: #7c2d12; color: white; border: none; border-radius: 5px; cursor: pointer; font-size: 12pt; z-index: 1000;">Print/Save as PDF</button>
    
    <div class="abbreviations">
        <h3>KEY ABBREVIATIONS</h3>
        <div class="abbr-item"><strong>STUMP</strong> = Smooth Muscle Tumor of Uncertain Malignant Potential | <strong>IVL</strong> = Intravenous Leiomyomatosis | <strong>ESS</strong> = Endometrial Stromal Sarcoma | <strong>LG-ESS</strong> = Low-Grade ESS | <strong>HG-ESS</strong> = High-Grade ESS</div>
        <div class="abbr-item"><strong>TAH-BSO</strong> = Total Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy | <strong>UTROSCT</strong> = Uterine Tumor Resembling Ovarian Sex Cord Tumor | <strong>MMMT</strong> = Malignant Mixed Mullerian Tumor (Carcinosarcoma)</div>
    </div>
    
    <table>
        <thead>
            <tr>
                <th>ENTITY</th>
                <th>CLINICAL</th>
                <th>GROSS</th>
                <th>HISTOLOGY</th>
                <th>IHC/STUDIES</th>
                <th>DDx</th>
                <th>KEY PEARLS</th>
            </tr>
        </thead>
        <tbody>
            <!-- NON-NEOPLASTIC -->
            <tr>
                <td class="entity-col">ADENOMYOSIS (C)</td>
                <td class="clinical-col">Most common non-neoplastic myometrial lesion; enlarged uterus, abnormal bleeding, dysmenorrhea; often with leiomyomas; commonly incidental hysterectomy finding</td>
                <td class="gross-col">Thickened myometrium with focal soft, discolored areas or small cysts</td>
                <td class="histo-col">Islands of endometrial glands surrounded by endometrial stroma within myometrium or exclusively endometrial stroma; glands often inactive, hemosiderin usually absent; <span class="high-yield">requires glands >2-2.5 mm from basalis in properly oriented section</span></td>
                <td class="ihc-col"><span class="high-yield">CD10+</span> (confirms endometrial stroma vs smooth muscle)</td>
                <td class="ddx-col">Tangentially cut normal endometrium (deeper levels show continuity); endometrial CA involving adenomyosis (malignant glands with cribriforming but surrounded by endometrial stroma, not myometrial invasion); invasive adenoCA (desmoplastic/inflammatory response); stromal tumor (no glands); adenomatoid tumor (mesothelial, no endometrial stroma)</td>
                <td class="pearls-col"><span class="high-yield">Properly oriented histologic section critical</span>; tangential cuts may mimic adenomyosis</td>
            </tr>
            
            <!-- BENIGN SMOOTH MUSCLE -->
            <tr>
                <td class="entity-col">LEIOMYOMA (C)</td>
                <td class="clinical-col"><span class="high-yield">Most common tumor in women/uterus</span>; rare <20 yrs, common >30 yrs; small asymptomatic, large cause pain, dysmenorrhea, urinary/bowel issues, infertility</td>
                <td class="gross-col">Often multiple; discrete, well-circumscribed, firm, whorled, tan-white; cystic degeneration in larger tumors; hyalinization/calcification; <span class="high-yield">NO coagulative necrosis</span>; 3 types: subserosal (beneath serosa, may be pedunculated), intramural (within myometrium), submucosal (beneath endometrium)</td>
                <td class="histo-col">Interlacing fascicles of bland monomorphic spindle cells; well-circumscribed; <span class="high-yield"><5 mitoses/10 hpf</span>; pseudocapsuled; hyalinized areas/calcifications; entire tumor may be hyalinized (infarcted); overlying endometrium may show endometritis if compressed<br><br><strong>Variants:</strong> Cellular (densely cellular, <5 mitoses, no necrosis/pleomorphism); Epithelioid (round polygonal cells, subtypes: leiomyoblastoma, clear cell, plexiform, <span class="high-yield">5-20 mitoses</span>); Bizarre/symplastic (giant cells, <5 mitoses, no necrosis); Lipoleiomyoma (mostly adipocytes); Mitotically active (<span class="high-yield"><5 mitoses, women <35</span>, no atypia/necrosis); IVL (extends into veins beyond uterus, no metastases); Benign metastasizing (distant sites like lungs, years after diagnosis)</td>
                <td class="ihc-col">Vimentin+, <span class="high-yield">desmin+, caldesmon+, SMA+</span>, CK- (rare+), ER/PR often+</td>
                <td class="ddx-col">Leiomyosarcoma (moderate-severe pleomorphism, hemorrhage, coagulative necrosis, >10 mitoses, infiltrating, possible metastases); stromal nodule (smaller bland cells like endometrial stroma, CD10+); LG-ESS (wormlike masses, bland cells, minimal cytoplasm, CD10+)</td>
                <td class="pearls-col"><span class="high-yield">Hormonally responsive</span> (shrink after menopause); <span class="high-yield">epithelioid, bizarre, IVL, and tumors in women >35 with mild atypia and >5 mitoses considered atypical/uncertain malignant potential</span></td>
            </tr>
            
            <!-- STUMP -->
            <tr>
                <td class="entity-col">STUMP</td>
                <td class="clinical-col"><span class="high-yield">High mitotic activity (>5-10/10 hpf) but lacking significant cytologic atypia and necrosis</span></td>
                <td class="gross-col">Variable</td>
                <td class="histo-col"><span class="high-yield">>5-10 mitoses/10 hpf without significant atypia or coagulative necrosis</span>; myxoid variant requires count in more cellular areas</td>
                <td class="ihc-col">Same as leiomyoma</td>
                <td class="ddx-col">Leiomyoma (fewer mitoses), leiomyosarcoma (atypia and/or necrosis)</td>
                <td class="pearls-col">Includes atypical epithelioid, bizarre, IVL variants; <span class="high-yield">uncertain behavior</span></td>
            </tr>
            
            <!-- LEIOMYOSARCOMA -->
            <tr>
                <td class="entity-col">LEIOMYOSARCOMA</td>
                <td class="clinical-col">Rapidly growing tumor in postmenopausal women; pain, dysmenorrhea, urinary/bowel issues; may have pelvic spread at presentation; distant metastases months-years later (lungs); incidental hysterectomy finding; Tx: TAH-BSO, tumor debulking, radiation; variable prognosis by stage/grade</td>
                <td class="gross-col">Usually solitary; large, poorly circumscribed, often beyond serosa; soft, fleshy, variegated with <span class="high-yield">hemorrhage and necrosis</span></td>
                <td class="histo-col">Densely cellular with interlacing fascicles of <span class="high-yield">pleomorphic spindled cells</span>; <span class="high-yield">coagulative necrosis</span> often present; <span class="high-yield">mitoses >10-20/10 hpf</span> in highest activity areas (40Ã— objective); infiltrative margins, occasional vascular invasion<br><br><strong>Variants:</strong> Epithelioid (rounded, highly atypical polygonal cells, necrosis, increased mitoses); Myxoid (myxoid matrix makes less cellular/mitotically active appearing, infiltrates myometrium/vessels)</td>
                <td class="ihc-col">Vimentin+, <span class="high-yield">SMA+, desmin+, caldesmon+</span>, ER/PR+ in better differentiated areas, CK-</td>
                <td class="ddx-col">Mitotically active leiomyoma (women <35, smaller, well-circumscribed, no necrosis/atypia/invasion); HG stromal sarcoma (evenly distributed small vessels, no fascicular pattern); LG-ESS (wormlike masses, bland cells, CD10+); metaplastic CA (malignant glands + spindle component)</td>
                <td class="pearls-col"><span class="high-yield">Large tumors (>10 cm) with necrosis and >10 mitoses have dismal prognosis (<5 yr survival)</span>; myxoid variant: count mitoses in cellular areas</td>
            </tr>
            
            <!-- STROMAL NODULE -->
            <tr>
                <td class="entity-col">STROMAL NODULE (AR)</td>
                <td class="clinical-col">Rare benign tumor; any age, generally older postmenopausal women; abnormal bleeding; palpably enlarged uterus</td>
                <td class="gross-col">Well-circumscribed, solid, soft, tan-gray mass; <span class="high-yield">unencapsulated with pushing margins</span></td>
                <td class="histo-col">Small uniform oval-to-spindled cells <span class="high-yield">resembling endometrial stromal cells</span>; minimal atypia; generally <10 mitoses/10 hpf; <span class="high-yield">numerous thin-walled vessels evenly spaced resembling spiral arterioles</span>; rare foci of necrosis, cystic degeneration, foam cells, calcification, decidualization, sex cord-like structures</td>
                <td class="ihc-col"><span class="high-yield">CD10+</span>, vimentin+, reticulin+ (surrounds individual cells), CK focally+ (except sex cord elements), SMA/desmin mostly- (except stromal myoma), EMA-</td>
                <td class="ddx-col">Leiomyoma (unevenly spaced thick-walled vessels, spindled cells, interlacing fascicles, SMA/desmin+); LG-ESS (infiltrative margins, prominent lymphovascular invasion); hemangiopericytoma (extremely rare, large staghorn vessels, pericytic differentiation)</td>
                <td class="pearls-col"><span class="high-yield">Benign without recurrence even if excised without hysterectomy</span>; usually ER/PR+</td>
            </tr>
            
            <!-- LOW-GRADE ESS -->
            <tr>
                <td class="entity-col">LOW-GRADE ESS (AR)</td>
                <td class="clinical-col">Rare; abnormal vaginal bleeding; any age, most common in older premenopausal/postmenopausal women; palpably enlarged uterus</td>
                <td class="gross-col">Well-circumscribed/diffusely infiltrative mass or multiple confluent masses; <span class="high-yield">wormlike masses in myometrium (lymphovascular invasion)</span>; hemorrhage, necrosis, cystic degeneration; extrauterine extension in ~30% at diagnosis</td>
                <td class="histo-col"><span class="high-yield">Extensively infiltrative margins</span>; <span class="high-yield">plugs in lymphovascular spaces and myometrium</span> (endolymphatic stromal myosis); variable mitoses, generally 10-20/10 hpf; cells with <span class="high-yield">minimal atypia resembling endometrial stromal cells</span>; foci of epithelioid differentiation (glandular/sex cord-like); occasional hemorrhage/necrosis; calcification, decidualization, cystic degeneration, foam cells may be seen</td>
                <td class="ihc-col"><span class="high-yield">CD10+</span>, vimentin+, CK occasionally focally+, EMA-, SMA/desmin mostly-<br><br><strong>Molecular:</strong> <span class="high-yield">t(7;17) JAZF1-SUZ12 fusion</span> most common; less common PHF1 rearrangements</td>
                <td class="ddx-col">Stromal nodule (no lymphovascular invasion, pushing margins); HG-ESS (marked atypia, atypical mitoses, necrosis); hemangiopericytoma (rare, staghorn vessels); IVL (smooth muscle, thick vessels, SMA/desmin+); metaplastic CA (malignant glands); adenosarcoma (epithelial nuclei not stromal)</td>
                <td class="pearls-col"><span class="high-yield">Mitotic activity NOT predictive of behavior</span>; distinction from HG-ESS: absence of marked atypia, minimal necrosis, no atypical mitoses; Tx: TAH-BSO with debulking; <span class="high-yield">recurrence common after years</span></td>
            </tr>
            
            <!-- HIGH-GRADE ESS -->
            <tr>
                <td class="entity-col">HIGH-GRADE (UNDIFF) ESS (F)</td>
                <td class="clinical-col">Rare in postmenopausal women; abnormal bleeding or pelvic pain; aggressive, <span class="high-yield"><50% 5-yr survival</span></td>
                <td class="gross-col">Grossly infiltrative masses, confluent mass, or diffuse myometrial infiltration; endometrial involvement, hemorrhage, necrosis common; <span class="high-yield">wormlike infiltration usually absent</span></td>
                <td class="histo-col"><span class="high-yield">Pronounced cytologic atypia</span>; cells may still resemble endometrial stromal cells; <span class="high-yield">mitoses >10/10 hpf with atypical forms</span>; uneven distribution of thin-walled vessels; <span class="high-yield">coagulative necrosis</span>; areas of undifferentiated bizarre/giant sarcoma cells; heterologous elements (rhabdomyo, chondrosarcoma); epithelioid foci and wormlike plugs generally absent; frequent lymphovascular invasion; may be indistinguishable from other uterine sarcomas (esp leiomyosarcoma)</td>
                <td class="ihc-col">Vimentin+, CK and CD10 focally+, EMA-, <span class="high-yield">SMA generally-</span> (useful vs leiomyosarcoma), S-100+ if chondrosarcoma component<br><br><strong>Molecular:</strong> <span class="high-yield">t(10;17) YWHAE-FAM22</span>; t(X;22) ZC3H7B-BCOR; BCOR ITD exon 15</td>
                <td class="ddx-col">LG-ESS (minimal atypia, evenly spaced vessels, wormlike projections); undiff endometrial sarcoma (lacks stromal differentiation); metaplastic CA (malignant epithelial + spindle); leiomyosarcoma (smooth muscle differentiation, whorling vs random); adenosarcoma (benign glands); other sarcomas (rare, lack stromal cells); poorly diff endometrial CA (CK+)</td>
                <td class="pearls-col"><span class="high-yield">Atypia more accurate than mitotic count for grading/predicting behavior</span>; necrosis present, epithelioid/wormlike projections absent; Tx: TAH-BSO with debulking; <span class="high-yield">distinction from leiomyosarcoma has no clinical significance</span></td>
            </tr>
            
            <!-- ADENOMYOMA -->
            <tr>
                <td class="entity-col">ADENOMYOMA (C)</td>
                <td class="clinical-col">Benign mixed epithelial-stromal lesion; may present with abnormal bleeding</td>
                <td class="gross-col">Well-circumscribed mass</td>
                <td class="histo-col">Benign endometrial glands surrounded by smooth muscle and endometrial stroma in varying proportions</td>
                <td class="ihc-col">Standard epithelial/stromal markers</td>
                <td class="ddx-col">Adenomyosis (irregular, not mass-forming); atypical polypoid adenomyoma (architectural complexity, cytologic atypia)</td>
                <td class="pearls-col">Benign lesion; smooth muscle component key feature</td>
            </tr>
            
            <!-- ATYPICAL POLYPOID ADENOMYOMA -->
            <tr>
                <td class="entity-col">ATYPICAL POLYPOID ADENOMYOMA (AR)</td>
                <td class="clinical-col">Polypoid lesion with abnormal bleeding; reproductive age women; associated with infertility</td>
                <td class="gross-col">Polypoid mass protruding into endometrial cavity</td>
                <td class="histo-col">Architecturally complex glands with cytologic atypia surrounded by <span class="high-yield">smooth muscle bundles</span>; squamous morular metaplasia common</td>
                <td class="ihc-col"><span class="high-yield">Stromal p16+</span> helps distinguish from myoinvasive endometrioid CA</td>
                <td class="ddx-col">Endometrial hyperplasia with squamous metaplasia (lacks smooth muscle); myoinvasive endometrioid CA (stromal desmoplasia, confluent glands, p16-); metaplastic CA (malignant spindle, high cellularity, pleomorphism, high mitoses)</td>
                <td class="pearls-col"><span class="high-yield">Distinguished by short smooth muscle bundles</span>; location and patient age helpful</td>
            </tr>
            
            <!-- CARCINOSARCOMA -->
            <tr>
                <td class="entity-col">CARCINOSARCOMA (MMMT) (AR)</td>
                <td class="clinical-col">Aggressive biphasic malignancy; postmenopausal women; abnormal bleeding; <span class="high-yield">poor prognosis</span></td>
                <td class="gross-col">Large polypoid mass filling endometrial cavity, often with necrosis</td>
                <td class="histo-col"><span class="high-yield">Malignant epithelial component</span> (usually high-grade endometrioid, serous, or clear cell CA) <span class="high-yield">AND malignant mesenchymal</span> (homologous: high-grade spindled/round/giant cells like fibrosarcoma, leiomyosarcoma, stromal sarcoma; <span class="high-yield">heterologous: rhabdomyosarcoma most common</span>, also chondrosarcoma, osteosarcoma, liposarcoma); scattered hybrid epithelial-spindle cells</td>
                <td class="ihc-col">Vimentin+ (both), CK 8/18+ (epithelial diffuse, spindle focal), desmin/myoglobin+ (rhabdomyo), S-100+ (chondro, lipo), CD10+ (stromal sarcoma)</td>
                <td class="ddx-col">Poorly diff endometrial CA (lacks biphasic, diffusely CK+); adenosarcoma (lacks malignant epithelial component)</td>
                <td class="pearls-col"><span class="high-yield">In curettage, often only carcinomatous component</span>; early mets epithelial; late mets both or spindle only (sarcomatous overgrowth); lungs common met site</td>
            </tr>
            
            <!-- ADENOMATOID TUMOR -->
            <tr>
                <td class="entity-col">ADENOMATOID TUMOR (AR)</td>
                <td class="clinical-col">Uncommon benign mesothelial tumor; incidental hysterectomy finding</td>
                <td class="gross-col">Small, well-circumscribed, firm nodule in myometrium</td>
                <td class="histo-col">Flat cuboidal epithelial lining in glandular spaces; mesothelial origin; no endometrial stroma</td>
                <td class="ihc-col">Mesothelial markers+</td>
                <td class="ddx-col">Adenomyosis (endometrial glands with endometrial stroma, CD10+); stromal tumor (no glands); endometrial CA involving adenomyosis (malignant glands)</td>
                <td class="pearls-col">Benign mesothelial lesion; distinct from adenomyosis</td>
            </tr>
            
            <!-- PECOMA -->
            <tr>
                <td class="entity-col">PECOMA (F)</td>
                <td class="clinical-col">Rare mesenchymal tumor with malignant potential; may be associated with <span class="high-yield">tuberous sclerosis</span></td>
                <td class="gross-col">Nodular mass, may be large</td>
                <td class="histo-col">Sheets/nests of large polygonal epithelioid cells with abundant eosinophilic or clear cytoplasm, prominent nucleoli; may include multinucleated and markedly pleomorphic forms; <span class="high-yield">perivascular distribution</span></td>
                <td class="ihc-col"><span class="high-yield">Melanocytic (HMB-45, Melan-A)+ AND myoid (SMA, desmin)+</span><br><br><strong>EM:</strong> Melanosomes and premelanosomes</td>
                <td class="ddx-col">Epithelioid leiomyoma (no melanocytic markers); epithelioid angiomyolipoma (typically renal); other epithelioid tumors</td>
                <td class="pearls-col"><span class="high-yield">Dual melanocytic and myoid differentiation</span>; malignant potential variable</td>
            </tr>
            
            <!-- UTROSCT -->
            <tr>
                <td class="entity-col">UTROSCT (F)</td>
                <td class="clinical-col">Rare tumor of uncertain histogenesis; most in peri/postmenopausal women; abnormal bleeding</td>
                <td class="gross-col">Well-circumscribed mass in myometrium</td>
                <td class="histo-col">Mixture of patterns resembling sex cord-stromal tumors: cords, trabeculae, hollow tubules, nests; cells small-medium with scant cytoplasm, bland nuclei; may have hyaline deposits; low mitotic activity</td>
                <td class="ihc-col">Variable: CK, vimentin, inhibin, calretinin, CD99, WT1; ER/PR often+; desmin and CD10 typically-</td>
                <td class="ddx-col">Endometrial stromal tumors with sex cord-like elements (CD10+, lack tubular architecture); metastatic ovarian sex cord-stromal tumor (clinical/radiologic correlation); epithelioid smooth muscle tumor (desmin+, no sex cord architecture)</td>
                <td class="pearls-col">Most benign behavior but rare malignant cases; complete excision recommended</td>
            </tr>
        </tbody>
    </table>
    
    <div class="key-concepts">
        <h2>KEY CONCEPTS</h2>
        
        <h3>Benign Smooth Muscle Tumors</h3>
        <ul>
            <li>Leiomyomas are the most common uterine tumor; variants include cellular, epithelioid, bizarre, lipoleiomyoma, mitotically active (in women <35), intravenous leiomyomatosis, and benign metastasizing leiomyoma</li>
            <li>Hormonally responsive (most shrink after menopause)</li>
        </ul>
        
        <h3>Malignant Smooth Muscle Tumors</h3>
        <ul>
            <li>Leiomyosarcomas characterized by hypercellularity, cytologic atypia, coagulative necrosis, and mitotic activity >10/10 hpf</li>
            <li>Large tumors (>10 cm) with coagulative necrosis and >10 mitoses/10 hpf have dismal prognosis (<5 years survival)</li>
        </ul>
        
        <h3>STUMP Criteria</h3>
        <ul>
            <li>High mitotic activity (>5-10/10 hpf) but lacking significant cytologic atypia and necrosis</li>
            <li>Atypical epithelioid, bizarre, and IVL variants also fall into uncertain malignant potential category</li>
        </ul>
        
        <h3>Endometrial Stromal Tumors</h3>
        <ul>
            <li>Distinguished by CD10 positivity, evenly spaced vessels resembling spiral arterioles, and characteristic translocations</li>
            <li>Low-grade ESS: JAZF1-SUZ12 fusion (t(7;17)); shows lymphovascular invasion with wormlike plugs</li>
            <li>High-grade ESS: YWHAE-FAM22 fusion (t(10;17)), ZC3H7B-BCOR fusion, or BCOR ITD</li>
            <li>Mitotic activity NOT predictive of aggressive behavior in low-grade ESS</li>
            <li>Cytologic atypia more accurate than mitotic count in distinguishing low-grade from high-grade and predicting behavior</li>
        </ul>
        
        <h3>Adenomyosis</h3>
        <ul>
            <li>Diagnosis requires endometrial glands >2-2.5 mm from basalis in properly oriented sections</li>
            <li>Distinguish from tangentially cut normal endometrium by examining deeper levels</li>
        </ul>
    </div>
    
    <div class="footer">
     
    </div>
</body>
</html>